Tue, February 20, 2024
Mon, February 19, 2024
Fri, February 16, 2024
Thu, February 15, 2024

Gil Blum Maintained (SRPT) at Strong Buy with Increased Target to $169 on, Feb 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-169-on-feb-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gil Blum of Needham, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $140 to $169 on, Feb 16th, 2024.

Gil has made no other calls on SRPT in the last 4 months.



There are 10 other peers that have a rating on SRPT. Out of the 10 peers that are also analyzing SRPT, 1 agrees with Gil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $128 on, Thursday, February 15th, 2024


These are the ratings of the 9 analyists that currently disagree with Gil


  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $145 on, Wednesday, February 14th, 2024
  • Kostas Biliouris of "BMO Capital" Initiated at Buy and Held Target at $170 on, Wednesday, January 31st, 2024
  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $224 on, Tuesday, January 30th, 2024
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $151 on, Thursday, January 25th, 2024
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $113 on, Wednesday, December 13th, 2023
  • Neena Bitritto-Garg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $109 on, Tuesday, December 12th, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $141 on, Thursday, November 2nd, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $115 on, Tuesday, October 31st, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $146 on, Tuesday, October 31st, 2023

Publication Contributing Sources